News
Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.
During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...
A local cancer survivor, Robert Dames, has released a new book titled "Cancer - What Now" to assist others in navigating the ...
ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.
Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...
Prostate-bed SBRT post-radical prostectomy is well-tolerated and delivers patient-reported outcomes comparable to CFRT, ...
Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.
Nuclidium has raised 79 million Swiss francs ($99 million) as the Swiss and German biotech looks to continue the clinical ...
The National Cancer Institute faces severe budget cuts, staff exodus, and halted research, threatening decades of progress ...
Researchers investigated how Mindfulness-Based Cancer Recovery and Tai Chi/Qijong interventions could reduce distress levels in cancer survivors.
Prostate and colorectal cancers are two of the most common cancers affecting men in the U.S., and Black men face ...
If you or someone you know has received a prostate cancer diagnosis, here's where to start, what to ask and how to plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results